Kyowa Kirin and Grünenthal collaborate on therapy portfolio
The deal covers 13 brands across six therapeutic areas, mainly focused on pain treatment
Read More
Tag: Kyoma
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
